Satisfaction With Pediatric Intravenous Catheter Placement in the Emergency Department

NCT ID: NCT00766181

Last Updated: 2010-05-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-10-31

Study Completion Date

2009-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine the satisfaction among parents and nurses of pediatric patients with IV catheter placement in the Emergency Department.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objectives of this study are to evaluate whether the proportion of parents satisfied with their child's IV placement procedure is higher after the introduction of Zingo compared to standard of care and to evaluate changes in nursing staff satisfaction with performing IV placement procedures after using Zingo prior to IV placement compared to standard of care.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intravenous Placement Procedure

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1: Lifestyle

Observatonal

No interventions assigned to this group

2: Lifestyle

Observational

Zingo TM (lidocaine hydrochloride monohydrate) powder intradermal injection system

Intervention Type BEHAVIORAL

0.5 mg lidocaine hydrochloride

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Zingo TM (lidocaine hydrochloride monohydrate) powder intradermal injection system

0.5 mg lidocaine hydrochloride

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* PHASE A: Parent of a pediatric patient from the age of 3 to 18 years of age who requires a peripheral IV placement in the Emergency Department
* Parent must be able to read and understand English and provide written informed consent
* Parent must be present during the IV placement
* PHASE B: Parent did not participate in Phase A
* Nurse has completed Zingo TM in-service training prior to participation
* Zingo is used prior to performing the IV placement procedure

Exclusion Criteria

\- Parent of patient with a serious unstable medical or psychological condition that would compromise participation in the study
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Covance

INDUSTRY

Sponsor Role collaborator

Anesiva, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Anesiva, Inc.

Related Links

Access external resources that provide additional context or updates about the study.

http://www.anesiva.com/

Anesiva home page

http://www.zingo.com

Zingo Product Information

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

113-03P

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.